Transplant recipients, who receive therapeutic immunosuppression to prevent graft rejection, are characterized by high coronavirus disease 2019 (COVID-19)-related mortality and defective response to vaccines. We observed that previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but not the standard two-dose regimen of vaccination, provided protection against symptomatic COVID-19 in kidney transplant recipients. We therefore compared the cellular and humoral immune responses of these two groups of patients. Neutralizing anti-Receptor Binding Domain (RBD) IgG antibodies were identified as the primary correlate of protection for transplant recipients. Analysis of virus-specific B and T cell responses suggested that the generation of neutralizing anti-RBD IgG may have depended upon cognate T-B cell interactions that took place in germinal center, potentially acting as a limiting checkpoint. High dose mycophenolate mofetil, an immunosuppressive drug, was associated with fewer antigen-specific B and T follicular helper (Tfh) cells after vaccination; this was not observed in patients recently infected with SARS-CoV-2. Finally, we observed that, in two independent prospective cohorts, administration of a third dose of SARS-CoV-2 mRNA vaccine restored neutralizing titers of anti-RBD IgG in about 40% of individuals who had not previously responded to two doses of vaccine. Together, these findings suggest that a third dose of SARS-CoV-2 mRNA vaccine improves the RBD-specific responses of transplant patients treated with immunosuppressive drugs. Description Infection with SARS-CoV-2 or a three-dose mRNA vaccine regimen elicit similar neutralizing antibody responses in some kidney transplant recipients.
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Vaccine, coronavirus, vaccination, Mortality, Vaccines, mRNA vaccine, Infection, Immunosuppression, immunosuppressive drugs, IgG antibody, Transplant, RBD, symptomatic, response, therapeutic, Patient, Neutralizing, humoral immune response, patients, T cell response, Neutralizing antibody response, Tfh, Neutralizing titer, cellular, kidney transplant recipients, administration, dose, immunosuppressive, Anti-RBD IgG, regimen, acute respiratory syndrome, cell interaction, recipients, individual, cohorts, description, rejection, two-dose regimen, Prevent, Cell, independent, IMPROVE, provided, characterized, suggested, elicit, two group, restored, acting, receive, follicular, infected with SARS-CoV-2, patients treated, took place, 【제목키워드】 SARS-CoV-2, mRNA vaccine, Neutralizing antibody response, kidney transplant recipient, dose, elicit,